Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancer.
Kwak E.
Oncologist. 2011;16(11):1498-507. Epub 2011 Oct 20. Review.
Related citations
Disparities between blacks and whites in tobacco and lung cancer treatment.
Park ER, Japuntich SJ, Traeger L, Cannon S, Pajolek H.
Oncologist. 2011;16(10):1428-34. Epub 2011 Sep 29.
Impact of new chemotherapeutic and targeted agents on survival in stage IV non-small cell lung cancer.
Yu JL, Simmons C, Victor JC, Han D, Hogeveen S, Leighl N, Verma S.
Oncologist. 2011;16(9):1307-15. Epub 2011 Aug 11.
Tumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancer.
Pirl WF, Traeger L, Greer JA, Bemis H, Gallagher E, Lennes I, Sequist L, Heist R, Temel JS.
Oncologist. 2011;16(9):1299-306. Epub 2011 Aug 1.
Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.
Lozano MD, Zulueta JJ, Echeveste JI, Gúrpide A, Seijo LM, Martín-Algarra S, Del Barrio A, Pio R, Idoate MA, Labiano T, Perez-Gracia JL.
Oncologist. 2011;16(6):877-85. Epub 2011 May 14.
Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.
Dai H, Hui Z, Ji W, Liang J, Lu J, Ou G, Zhou Z, Feng Q, Xiao Z, Chen D, Zhang H, Yin W, He J, Wang L.
Oncologist. 2011;16(5):641-50. Epub 2011 Apr 11.
Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data.
Le Péchoux C.
Oncologist. 2011;16(5):672-81. Epub 2011 Mar 4. Review.
Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic.
Janku F, Tsimberidou AM, Wang X, Hong DS, Naing A, Gong J, Garrido-Laguna I, Parsons HA, Zinner RG, Kurzrock R.
Oncologist. 2011;16(3):327-35. Epub 2011 Feb 21.
Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
Mak RH, Digumarthy SR, Muzikansky A, Engelman JA, Shepard JA, Choi NC, Sequist LV.
Oncologist. 2011;16(3):319-26. Epub 2011 Feb 21.
Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
Mendoza TR, Wang XS, Lu C, Palos GR, Liao Z, Mobley GM, Kapoor S, Cleeland CS.
Oncologist. 2011;16(2):217-27. Epub 2011 Feb 1.
Forgotten histories.
Boulmay BC.
Oncologist. 2011;16(4):537-8. Epub 2011 Mar 4. No abstract available.
Bevacizumab treatment to progression after chemotherapy: outcomes from a U.S. community practice network.
Nadler E, Yu E, Ravelo A, Sing A, Forsyth M, Gruschkus S.
Oncologist. 2011;16(4):486-96. Epub 2011 Mar 25.
18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature review.
Moller AK, Loft A, Berthelsen AK, Damgaard Pedersen K, Graff J, Christensen CB, Perell K, Petersen BL, Daugaard G.
Oncologist. 2011;16(4):445-51. Epub 2011 Mar 22. Review.
Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC.
Mak RH, Doran E, Muzikansky A, Kang J, Neal JW, Baldini EH, Choi NC, Willers H, Jackman DM, Sequist LV.
Oncologist. 2011;16(6):886-95. Epub 2011 May 31.
Approval summary: pemetrexed maintenance therapy of advanced/metastatic nonsquamous, non-small cell lung cancer (NSCLC).
Cohen MH, Cortazar P, Justice R, Pazdur R.
Oncologist. 2010;15(12):1352-8. Epub 2010 Dec 10.
Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).
Cohen MH, Johnson JR, Chattopadhyay S, Tang S, Justice R, Sridhara R, Pazdur R.
Oncologist. 2010;15(12):1344-51. Epub 2010 Dec 10.
Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimens.
Grossi F, Kubota K, Cappuzzo F, de Marinis F, Gridelli C, Aita M, Douillard JY.
Oncologist. 2010;15(10):1102-12. Epub 2010 Oct 7. Review.
Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer.
Thatcher N, Heighway J.
Oncologist. 2010;15(10):1034-42. Epub 2010 Oct 7. Review.
Adjuvant therapy in non-small cell lung cancer: current and future directions.
Sangha R, Price J, Butts CA.
Oncologist. 2010;15(8):862-72. Epub 2010 Aug 3. Review.
Economic burden for informal caregivers of lung and colorectal cancer patients.
Van Houtven CH, Ramsey SD, Hornbrook MC, Atienza AA, van Ryn M.
Oncologist. 2010;15(8):883-93. Epub 2010 Jul 28.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on